Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
| 347.8 | |
| 352 | |
| - | |
| 352 | |
| 345.3 | |
| 213-418.7 | |
| 11 031 M | |
| 35.9184 | |
| 31 002 K | |
| 2 030 M | |
| 1.356 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
There's been a notable change in appetite for Medpace Holdings, Inc. (NASDAQ:MEDP) shares in the week since its second-quarter report, with the stock down 13% to US$382. The result was positive overal...
Medpace Holdings (NASDAQ:MEDP) Second Quarter 2024 Results Key Financial Results Revenue: US$528.1m (up 15% from 2Q 2023). Net income: US$88.4m (up 45% from 2Q 2023). Profit margin: 17% (up from 13%...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
